Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SINGLE-AF
NCT04437654Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jul 2020
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban, rivaroxaban in Atrial fibrillation (AFib), sponsored by Yonsei University. Started Jul 2020; status: completed.
02
Drugs
apixabanrivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04437654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437654.